Treatment of Metastatic Adrenal Cortical Carcinoma with Etoposide (VP-16) and Cisplatin after Failure with o,p′DDD: Clinical Case Reports

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 3, 1996, Pages 229-231

  Zidan, J ^a,b   Shpendler, M ^a   Robinson, E ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Adrenal cortical carcinoma; Cisplatin; Etoposide; Mitotane; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOTROPIN; DEXAMETHASONE; ETOPOSIDE; HYDROCORTISONE; MITOTANE; PRASTERONE; THYROXINE;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER METASTASIS; LUNG METASTASIS; PHYSICAL EXAMINATION; THROMBOCYTOPENIA;

ADRENAL CORTEX NEOPLASMS; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; LIVER NEOPLASMS; MITOTANE;

EID: 0030010579     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199606000-00003     Document Type: Article

References (16)

1. Hutter AM, Kayhoe DE. Adrenal cortical carcinoma: clinical features of 138 patients. Am J Med 1966;41:572-80.
2. Zeffren J, Yagoda A. Chemotherapy of adrenal cortical carcinoma. In: Spiera ASD, ed. Chemotherapy and urological malignancies. New York: Springer Verlag, 1982:1-8.
3. Didolkar MS, Bescher RA, Elias EG, Moore RH. Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 1981;47:2153-61.
4. King Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 patients. Cancer 1979;44:239-44.
5. Samaan AN, Hickey CR. Adrenal cortical carcinoma. Semin Oncol 1987;14:292-6.
6. Macfarlane DA. Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of 55 cases. Ann R Coll Surg Engl 1958;23:155.
7. Lubitz JA, Freeman L, Okun R. Mitotane in inoperable adrenal cortical carcinoma. JAMA 1973;223:1109-11.
8. Boven E, Vermorker J, van Slooten H, Pinedo H. Complete response of metastasized adrenal cortical carcinoma with o.p′DDD. Cancer 1984;53:26-9.
9. Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992;112:963-70.
10. Tattersall MHN, Lander H, Bain B, et al. Cisplatin treatment of metastatic adrenal carcinoma. Med J Aust 1980;1:419-21.
11. Grapski RT, Lopez JA, Krikorian JG. Cisplatin chemotherapy of adrenocortical carcinoma. Proc Annu Meet Ann Soc Clin Oncol [Abstract] 1983;2:232.
12. van Slooten H, van Oosteron AT. CAP (cyclophosphamide, doxorubicin and cisplatin) regimen in adrenal cortical carcinoma. Cancer Treat Rep 1983;67:377-9.
13. Haq MM, Legha SS, Samaan NA, et al. Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat Rep 1980;64:909-13.
14. Schlumberger M, Brugieres L, Gicquel Ch, et al. 5-Fluorouracil, doxorubicin and cisplatin as treatment for adrenal cortical carcinoma. Cancer 1991;67:2997-3000.
15. Bukowski RM, Wolfe M, Levine HS, et al. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group Study. J Clin Oncol 1993;11:161-5.
16. Johnson HD, Greco A. Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16). Cancer 1986;58: 2198-202.